Latigo Biotherapeutics
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain. The company aims to target pain at its source to provide effective, rapid-acting pain relief without the risk of addiction. Their lead program targets Nav1.8, a validated human pain target, leveraging internal ion channel expertise.
Domain
latigobio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$150.0M
Founded
2017
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Latigo Biotherapeutics use?+
Latigo Biotherapeutics uses 17 technologies including Google Analytics, Google Tag Manager, Slider Revolution.
What industry is Latigo Biotherapeutics in?+
Latigo Biotherapeutics operates in the Biotechnology industry.
Where is Latigo Biotherapeutics based?+
Latigo Biotherapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026